BlackRock’s DexCom DXCM Stock Holding History

BlackRock’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-272,000	Closed	-$37.7M	–	5302
2024 Q1	$37.7M	Buy	+272,000	New	+$34.2M	﹤0.01%	2617
2023 Q1	–	Sell	-347,000	Closed	-$39.3M	–	5603
2022 Q4	$39.3M	Hold	347,000	–	–	﹤0.01%	2630
2022 Q3	$27.9M	Buy	+347,000	New	+$29.4M	﹤0.01%	2844
2022 Q1	–	Sell	-238,800	Closed	-$32.1M	–	5835
2021 Q4	$32.1M	Sell	238,800 -2,800	-1%	-$402K	﹤0.01%	2981
2021 Q3	$33M	Buy	+241,600	New	+$30.5M	﹤0.01%	2934

Other funds holding DXCM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

BlackRock's DXCM Position: Q1 2026 in Review

BlackRock reduced its DexCom (DXCM) stake by 2.2% in Q1 2026, selling an estimated $61.6M and leaving 38,964,371 shares worth $2.45B. The position accounts for 0.04% of the portfolio, ranked #356.

BlackRock first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.71B in Q1 2024. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

BlackRock held 38,964,371 shares of DexCom worth $2.45B as of Q1 2026.
BlackRock sold 884,006 DexCom shares in Q1 2026, an estimated $61.6M.
DexCom made up 0.04% of BlackRock's portfolio in Q1 2026, its #356 holding.
BlackRock first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
BlackRock's DexCom position peaked at $4.71B in Q1 2024.
957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.